- Drug Pipelines
- April 2024
- 202 Pages
Global
From €7656EUR$7,950USD£6,584GBP
- Report
- February 2024
- 120 Pages
Global
From €3500EUR$3,893USD£3,115GBP
- Drug Pipelines
- November 2019
- 37 Pages
Global
From €1926EUR$2,000USD£1,656GBP
- Report
- May 2024
- 50 Pages
Global
From €2552EUR$2,650USD£2,195GBP
- Report
- May 2024
- 50 Pages
Global
From €2552EUR$2,650USD£2,195GBP
- Report
- May 2024
- 50 Pages
Global
From €2552EUR$2,650USD£2,195GBP
Pilocarpine is a drug used to treat immune disorders, such as dry mouth caused by Sjogren's syndrome, an autoimmune disorder. It is also used to treat symptoms of myasthenia gravis, an autoimmune disorder that causes muscle weakness. Pilocarpine is a cholinergic agonist, meaning it stimulates the release of acetylcholine, a neurotransmitter that helps regulate the immune system. It is available in both oral and topical forms, and is often used in combination with other drugs to treat immune disorders.
Pilocarpine is used to treat a variety of immune disorders, including dry mouth, myasthenia gravis, and autoimmune diseases. It is also used to treat glaucoma, a condition caused by increased pressure in the eye. Pilocarpine is available in both oral and topical forms, and is often used in combination with other drugs to treat immune disorders.
Some companies in the Pilocarpine market include Allergan, Merck, and Novartis. Show Less Read more